<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
    
    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
        <!-- AppResources meta begin -->
        <meta name="paf-app-resources" content="" />
                 <script type="text/javascript">var ncbi_startTime = new Date();</script>
            
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="" />

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="books" /><meta name="ncbi_pdid" content="book-part" /><meta name="ncbi_acc" content="NBK548105" /><meta name="ncbi_domain" content="livertox" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/NBK548105/" /><meta name="ncbi_pagename" content="Chloramphenicol - LiverTox - NCBI Bookshelf" /><meta name="ncbi_bookparttype" content="chapter" /><meta name="ncbi_app" content="bookshelf" />
        <!-- Logger end -->
        
        <title>Chloramphenicol - LiverTox - NCBI Bookshelf</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.15.2/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.15.2/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,FOLLOW,NOARCHIVE" /><meta name="citation_inbook_title" content="LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]" /><meta name="citation_title" content="Chloramphenicol" /><meta name="citation_publisher" content="National Institute of Diabetes and Digestive and Kidney Diseases" /><meta name="citation_date" content="2017/01/24" /><meta name="citation_pmid" content="31643435" /><meta name="citation_fulltext_html_url" content="https://www.ncbi.nlm.nih.gov/books/NBK548105/" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="DC.Title" content="Chloramphenicol" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="National Institute of Diabetes and Digestive and Kidney Diseases" /><meta name="DC.Date" content="2017/01/24" /><meta name="DC.Identifier" content="https://www.ncbi.nlm.nih.gov/books/NBK548105/" /><meta name="description" content="Chloramphenicol is a broad spectrum antibiotic introduced into clinical practice in 1948, but which was subsequently shown to cause serious and fatal aplastic anemia and is now used rarely and reserved for severe, life-threatening infections for which other antibiotics are not available. Chloramphenicol has also been linked to cases of acute, clinically apparent liver injury with jaundice, largely in association with aplastic anemia." /><meta name="og:title" content="Chloramphenicol" /><meta name="og:type" content="book" /><meta name="og:description" content="Chloramphenicol is a broad spectrum antibiotic introduced into clinical practice in 1948, but which was subsequently shown to cause serious and fatal aplastic anemia and is now used rarely and reserved for severe, life-threatening infections for which other antibiotics are not available. Chloramphenicol has also been linked to cases of acute, clinically apparent liver injury with jaundice, largely in association with aplastic anemia." /><meta name="og:url" content="https://www.ncbi.nlm.nih.gov/books/NBK548105/" /><meta name="og:site_name" content="NCBI Bookshelf" /><meta name="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-livertox-lrg.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbibooks" /><meta name="bk-non-canon-loc" content="/books/n/livertox/Chloramphenicol/" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/books/NBK548105/" /><link rel="stylesheet" href="/corehtml/pmc/css/figpopup.css" type="text/css" media="screen" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books_print.min.css" type="text/css" media="print" /><style type="text/css">p a.figpopup{display:inline !important} .bk_tt {font-family: monospace}  .first-line-outdent .bk_ref {display: inline}  .body-content h2, .body-content .h2  {border-bottom: 1px solid #97B0C8} .body-content h2.inline {border-bottom: none} a.page-toc-label , .jig-ncbismoothscroll a {text-decoration:none;border:0 !important} .temp-labeled-list  .graphic {display:inline-block !important} .temp-labeled-list  img{width:100%}</style><script type="text/javascript" src="/corehtml/pmc/js/jquery.hoverIntent.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/large-obj-scrollbars.min.js"> </script><script type="text/javascript">window.name="mainwindow";</script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/book-toc.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/books.min.js"> </script><meta name="book-collection" content="NONE" />

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="CE8C7B40046641C100000000052D019D.m_12" />
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4192745/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4098876/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/4008682/3881636/3579733/4062871/12930/3964959/3854974/36029/4128070/9685/3549676/3609192/3609193/3609213/3395586.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4192745/css/3411343/3882866.css" media="print" /></head>
    <body class="book-part">
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4192745/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>
                            <div class="header">
    <div class="res_logo"><h1 class="res_name"><a href="/books/" title="Bookshelf home">Bookshelf</a></h1><h2 class="res_tagline"></h2></div>
    <div class="search"><form method="get" action="/books/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="books" selected="selected" class="last" data-ac_dict="bookshelf-search">Books</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books" data-ac_dict="bookshelf-search">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc">PMC</option><option value="popset">PopSet</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="protfam">Protein Family Models</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search Books. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'bookshelf-search',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'no'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/books/browse/">Browse Titles</a>
                    </li><li>
                        <a href="/books/advanced/">Advanced</a>
                    </li><li class="help">
                        <a href="/books/NBK3833/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <!-- Custom content 1 -->
<div class="col1">
    
</div>

<div class="container">
    <div id="maincontent" class="content eight_col col">
        <!-- Custom content in the left column above book nav -->
        <div class="col2">
            
        </div>
        
        <!-- Book content -->
        

        <!-- Custom content between navigation and content -->
        <div class="col3">
            
        </div>
        
        <div class="document">
            <div class="pre-content"><div><div class="bk_prnt"><p class="small">NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.</p><p>LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012-. </p></div><div class="iconblock clearfix whole_rhythm no_top_margin bk_noprnt"><a class="img_link icnblk_img" title="All Drug Records" href="/books/n/livertox/"><img class="source-thumb" src="/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-livertox-lrg.png" alt="Cover of LiverTox" height="100px" width="80px" /></a><div class="icnblk_cntnt eight_col"><h2>LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet].</h2><a data-jig="ncbitoggler" href="#__NBK548105_dtls__">Show details</a><div style="display:none" class="ui-widget" id="__NBK548105_dtls__"><div>Bethesda (MD): <a href="https://www.niddk.nih.gov/" ref="pagearea=page-banner&amp;targetsite=external&amp;targetcat=link&amp;targettype=publisher">National Institute of Diabetes and Digestive and Kidney Diseases</a>; 2012-.</div></div><div class="half_rhythm"><ul class="inline_list"><li style="margin-right:1em"><a class="bk_cntns" href="/books/n/livertox/">Drug Records</a></li></ul></div><div class="bk_noprnt"><form method="get" action="/books/n/livertox/" id="bk_srch"><div class="bk_search"><label for="bk_term" class="offscreen_noflow">Search term</label><input type="text" title="Search this book" id="bk_term" name="term" value="" data-jig="ncbiclearbutton" /> <input type="submit" class="jig-ncbibutton" value="Search this book" submit="false" style="padding: 0.1em 0.4em;" /></div></form></div></div><div class="icnblk_cntnt two_col"><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/livertox/Chlorambucil/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/livertox/Chlordiazepoxide/" title="Next page in this title">Next &gt;</a></div></div></div></div></div>
            <div class="main-content lit-style" itemscope="itemscope" itemtype="http://schema.org/CreativeWork"><div class="meta-content fm-sec"><h1 id="_NBK548105_"><span class="title" itemprop="name">Chloramphenicol</span></h1><p class="small">Last Update: <span itemprop="dateModified">January 24, 2017</span>.</p></div><div class="body-content whole_rhythm" itemprop="text"><div id="Chloramphenicol.OVERVIEW"><h2 id="_Chloramphenicol_OVERVIEW_">OVERVIEW</h2><div id="Chloramphenicol.Introduction"><h3>Introduction</h3><p>Chloramphenicol is a broad spectrum antibiotic introduced into clinical practice in 1948, but which was subsequently shown to cause serious and fatal aplastic anemia and is now used rarely and reserved for severe, life-threatening infections for which other antibiotics are not available. Chloramphenicol has also been linked to cases of acute, clinically apparent liver injury with jaundice, largely in association with aplastic anemia.</p></div><div id="Chloramphenicol.Background"><h3>Background</h3><p>Chloramphenicol (klor" am fen' i kol) is an antibiotic initially isolated from Streptomyces venezuelae and later characterized biochemically and synthesized. Chloramphenicol was introduced into clinical practice in 1948 under the brand name Chloromycetin and became a widely used antibiotic because of its oral availability, excellent tolerability and wide spectrum of activity. Chloramphenicol has bacteriostatic activity against many gram positive and gram negative organisms, both aerobic and anaerobic including H. influenza, N meningitides, S. pneumoniae, N gonorrhoeae, Brucella species and Bordetella pertussis. It also has activity against many spirochaetes, rickettsiae, chlamydiae and mycoplasmas. Chloramphenicol is thought to act by binding to the 50S ribosomal subunit in bacteria, thus inhibiting bacterial protein synthesis. A similar inhibition of protein synthesis may occur in mitochondria. Within a few years of its introduction, chloramphenicol was linked to rare cases of aplastic anemia and later to other fatal blood dyscrasias including thrombocytopenia, neutropenia and pure red cell aplasia. In addition, cases of leukemia were identified in children who had recovered from blood dyscrasias attributed to chloramphenicol. By the early 1960s, more than 1000 cases of severe bone marrow aplasia were attributed to use of chloramphenicol and it was widely banned or placed under restrictions, particularly in children. Currently, chloramphenicol is available only in parenteral forms, and its use is restricted to severe, life-threatening infections for which no other antibiotic is available because of antibiotic resistance or drug allergy. Several generic forms of chloramphenicol for intravenous administration are available and the recommended dose is 50 mg/kg daily in 4 divided doses. Monitoring for blood counts is recommended and prompt discontinuation for any evidence of myelosuppression.</p></div><div id="Chloramphenicol.Hepatotoxicity"><h3>Hepatotoxicity</h3><p>A proportion of patients with blood dyscrasias due to chloramphenicol also developed clinically apparent liver injury with jaundice, usually occurring before the appearance of aplastic anemia or severe thrombocytopenia. <a class="def" href="/books/n/livertox/glossary/def-item/glossary.jaundice/">Jaundice</a> arises in 10% to 25% of cases of aplastic anemia, usually within 1 to 2 months of starting chloramphenicol and often shortly after it is stopped. Aplastic anemia and the accompanying liver injury occur most frequently in patients who receive multiple courses of chloramphenicol or prolonged therapy. The serum enzyme pattern is usually hepatocellular and the clinical presentation is an acute hepatitis-like syndrome with onset of fatigue, nausea, anorexia and abdominal discomfort followed by dark urine and jaundice. Rare instances have a cholestatic pattern of presentation with jaundice and itching and prominent elevations in alkaline phosphatase. Some cases occur in the absence of bone marrow involvement. Immunoallergic and autoimmune features are rarely present. The course is self-limited in most instances, but examples of acute liver failure have been reported, particularly in patients without aplastic anemia. In most cases, however, the liver injury associated with chloramphenicol use is eclipsed by the severe bone marrow aplasia.</p><p>Likelihood score: B (highly likely cause of clinically apparent liver injury, now rarely seen).</p></div><div id="Chloramphenicol.Mechanism_of_Injury"><h3>Mechanism of Injury</h3><p>The etiology of liver injury associated with chloramphenicol is likely idiosyncratic and probably immunological. The hepatitis that accompanies chloramphenicol induced aplastic anemia is similar to the hepatitis that occurs with spontaneous or idiopathic aplastic anemia, suggesting a common pathogenesis of bone marrow and hepatic progenitor cell injury and loss. The marrow toxicity of chloramphenicol has been attributed to the nitrophenyl group in the molecule which is unique among microbial derived antibiotics.</p></div><div id="Chloramphenicol.Outcome_and_Management"><h3>Outcome and Management</h3><p>The liver injury accompanying blood dyscrasias caused by chloramphenicol is often severe, but resolves rapidly in most cases only to be followed by signs and symptoms of bone marrow failure. <a class="def" href="/books/n/livertox/glossary/def-item/glossary.acute-liver-failure/">Acute liver failure</a> can result, but the role of liver transplantation in this situation is difficult because of the accompanying marrow damage and aplasia.</p><p>Drug Class: <a href="/books/n/livertox/Antiinfective/">Antiinfective Agents</a>, Miscellaneous</p></div></div><div id="Chloramphenicol.PRODUCT_INFORMATION"><h2 id="_Chloramphenicol_PRODUCT_INFORMATION_">PRODUCT INFORMATION</h2><div id="Chloramphenicol.BPI" class="box"><p><b>REPRESENTATIVE TRADE NAMES</b></p><p>Chloramphenicol &#x02013; Generic, Chloromycetin&#x000ae;</p><p><b>DRUG CLASS</b></p><p>Antiinfective Agents</p><p><a href="https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&#x00026;query=Chloramphenicol" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">COMPLETE LABELING</a></p><p>Product labeling at DailyMed, National Library of Medicine, NIH</p></div></div><div id="Chloramphenicol.CHEMICAL_FORMULA_AND_STR"><h2 id="_Chloramphenicol_CHEMICAL_FORMULA_AND_STR_">CHEMICAL FORMULA AND STRUCTURE</h2><div id="Chloramphenicol.T1" class="table"><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK548105/table/Chloramphenicol.T1/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__Chloramphenicol.T1_lrgtbl__"><table><thead><tr><th id="hd_h_Chloramphenicol.T1_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">DRUG</th><th id="hd_h_Chloramphenicol.T1_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">CAS REGISTRY NO</th><th id="hd_h_Chloramphenicol.T1_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">MOLECULAR FORMULA</th><th id="hd_h_Chloramphenicol.T1_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">STRUCTURE</th></tr></thead><tbody><tr><td headers="hd_h_Chloramphenicol.T1_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Chloramphenicol</td><td headers="hd_h_Chloramphenicol.T1_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://pubchem.ncbi.nlm.nih.gov/substance/134972919" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubchem">56-75-7</a></td><td headers="hd_h_Chloramphenicol.T1_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">C11-H12-Cl2-N2-O5</td><td headers="hd_h_Chloramphenicol.T1_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><div class="graphic"><img src="/books/NBK548105/bin/Chloramphenicol_structure.jpg" alt="Chloramphenicol chemical structure" /></div></td></tr></tbody></table></div></div></div><div id="Chloramphenicol.ANNOTATED_BIBLIOGRAPHY"><h2 id="_Chloramphenicol_ANNOTATED_BIBLIOGRAPHY_">ANNOTATED BIBLIOGRAPHY</h2><p>References updated: 24 January 2017</p><ul class="first-line-outdent"><li><div class="bk_ref" id="Chloramphenicol.R1">Zimmerman HJ. Chloramphenicol. Hepatic injury from the treatment of infectious and parasitic diseases. In, Zimmerman HJ. Hepatotoxicity: the adverse effects of drugs and other chemicals on the liver. 2nd ed. Philadelphia: Lippincott, 1999. pp 589-92.<div><i>(Expert review of hepatotoxicity published in 1999 mentions that the hepatic injury from chloramphenicol is eclipsed by its vastly more important myelotoxicity, but that at least 25 cases of liver injury with jaundice have been reported, usually with hepatocellular injury).</i></div></div></li><li><div class="bk_ref" id="Chloramphenicol.R2">Moseley RH. Antibacterial and Antifungal Agents. In, Kaplowitz N, DeLeve LD, eds. Drug-induced liver disease. 3rd Edition. Amsterdam: Elsevier, 2013. p. 463-81.<div><i>(Review of hepatotoxicity of antibiotics; chloramphenicol is not discussed).</i></div></div></li><li><div class="bk_ref" id="Chloramphenicol.R3">MacDougall C, Chambers HF. Chloramphenicol. Protein synthesis inhibitors and miscellaneous antibacterial agents. In, Brunton LL, Chabner BA, Knollman BC, eds. Goodman &#x00026; Gilman&#x02019;s the pharmacological basis of therapeutics. 12th ed. New York: McGraw-Hill, 2011, pp. 1526-9.<div><i>(Textbook of pharmacology and therapeutics).</i></div></div></li><li><div class="bk_ref" id="Chloramphenicol.R4">Rich ML, Ritterhoff RJ, Hoffmann RJ. A fatal case of aplastic anemia following chloramphenicol (chloromycetin) therapy. Ann Intern Med 1950; 33: 1459-67.  [<a href="/pubmed/14790529" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 14790529</span></a>]<div><i>(63 year old man developed purpura 3 months after starting chloramphenicol, with subsequent aplastic anemia and death 2 weeks later; no mention of liver injury or jaundice).</i></div></div></li><li><div class="bk_ref" id="Chloramphenicol.R5">Volini IF, Greenspan I, Ehrlich L, Gonner JA, Felsenfeld O, Schwartz SO. Hemopoietic changes during administration of chloramphenicol (chloromycetin). J Am Med Assoc 1950; 142: 1333-35.  [<a href="/pubmed/15412135" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15412135</span></a>]<div><i>(Three African-American males developed reversible granulocytopenia during chloramphenicol therapy despite beneficial response to the antibiotic).</i></div></div></li><li><div class="bk_ref" id="Chloramphenicol.R6">Winternitz C. Fatal aplastic anemia following chloramphenicol (chloromycetin) therapy. Calif Med 1952; 77: 335-9.  [<a href="/pmc/articles/PMC1521482/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1521482</span></a>] [<a href="/pubmed/13009486" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 13009486</span></a>]<div><i>(35 year old woman developed fatigue followed by jaundice one month after starting chloramphenicol [bilirubin 14.3 mg/dL, ALT and Alk P not available], with subsequent appearance of petechiae and aplastic anemia resulting in death within the next 3 weeks).</i></div></div></li><li><div class="bk_ref" id="Chloramphenicol.R7">Rheingold JJ, Spurling CL. Chloramphenicol and aplastic anemia. J Am Med Assoc 1952; 119 (14): 1301-4.  [<a href="/pubmed/14938166" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 14938166</span></a>]<div><i>(5 cases of fatal aplastic anemia developed in 4 women and one man, ages 18-36 years, who had taken chloramphenicol within the previous two months, none with hepatitis or jaundice).</i></div></div></li><li><div class="bk_ref" id="Chloramphenicol.R8">Sturgeon P. Fatal aplastic anemia in children following chloramphenicol (chloromycetin) therapy; report of four cases. J Am Med Assoc 1952; 149: 918-22.  [<a href="/pubmed/14938069" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 14938069</span></a>]<div><i>(4 children were admitted to a Los Angeles referral hospital over a 2 year period with aplastic anemia after chloramphenicol treatment, ages 2-6 years, 2-6 weeks after course of chloramphenicol resulting in fatal outcome, no mention of liver injury or jaundice).</i></div></div></li><li><div class="bk_ref" id="Chloramphenicol.R9">Claudon DB, Holbrook AA. Fatal aplastic anemia associated with chloramphenicol (chloromycetin) therapy; report of two cases. J Am Med Assoc 1952; 149: 912-4.  [<a href="/pubmed/14938067" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 14938067</span></a>]<div><i>(71 year old woman and 92 year old man developed aplastic anemia 2 and 6 weeks after multiple courses of chloramphenicol with fatal outcomes and aplasia of marrow; no mention of hepatitis or jaundice).</i></div></div></li><li><div class="bk_ref" id="Chloramphenicol.R10">Hargraves MM, Mills SD, Heck FJ. Aplastic anemia associated with administration of chloramphenicol. J Am Med Assoc 1952; 119: 1293-1300.  [<a href="/pubmed/14938165" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 14938165</span></a>]<div><i>(Description of 10 cases of aplastic anemia possibly attributable to use of chloramphenicol: latency 1-6 weeks, often with prolonged, intermittent or multiple courses, five in children, 7 fatal, one with jaundice preceding onset of petechiae and subsequent aplastic anemia).</i></div></div></li><li><div class="bk_ref" id="Chloramphenicol.R11">Hargraves MM. Aplastic anemia associated with the administration of chloramphenicol. Proc Staff Meet Mayo Clin 1952; 27: 280-1.  [<a href="/pubmed/14941875" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 14941875</span></a>]<div><i>(Further information on 6 cases of aplastic anemia attributed to chloramphenicol [Hargraves 1952], most of which were fatal, precipitous in onset and not responsive to corticosteroid or vitamin B12 administration).</i></div></div></li><li><div class="bk_ref" id="Chloramphenicol.R12">Smiley RK, Cartwright GE, Wintrobe MM. Fatal aplastic anemia following chloramphenicol (chloromycetin) administration. J Am Med Assoc 1952; 149: 914-8.  [<a href="/pubmed/14938068" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 14938068</span></a>]<div><i>(3 cases of fatal aplastic anemia in one 29 year old man and two young girls [6 and 8 years old] arising within a few weeks of exposure to chloramphenicol [all with prolonged or intermittent courses], without jaundice or liver injury).</i></div></div></li><li><div class="bk_ref" id="Chloramphenicol.R13">Hawkins LA, Lederer H. Fatal aplastic anaemia after chloramphenicol treatment. Br Med J 1952; 2 (4781): 423-6.  [<a href="/pmc/articles/PMC2021158/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2021158</span></a>] [<a href="/pubmed/14944846" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 14944846</span></a>]<div><i>(Two girls, ages 4 and 7, developed jaundice 39 and 49 days after starting 27- and 44-day courses of chloramphenicol for whooping cough [liver tests not provided] which lasted for a few days and was followed by bruising and progressive, ultimately fatal aplastic anemia).</i></div></div></li><li><div class="bk_ref" id="Chloramphenicol.R14">Wolman B. Fatal aplastic anaemia after chloramphenicol. Br Med J 1952; 2 (4781): 426-7.  [<a href="/pmc/articles/PMC2021160/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2021160</span></a>] [<a href="/pubmed/14944847" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 14944847</span></a>]<div><i>(6 year old developed fatigue and jaundice followed by bruising one month after finishing a 24 day course of chloramphenicol [bilirubin, ALT and Alk P not given], with subsequent aplastic anemia and death within a month; at autopsy the liver was enlarged and showed fatty change).</i></div></div></li><li><div class="bk_ref" id="Chloramphenicol.R15">Salm R. Acute necrosis of the liver following chloramphenicol therapy. Edinb Med J 1953; 60: 334-6.  [<a href="/pmc/articles/PMC5290421/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5290421</span></a>] [<a href="/pubmed/13060295" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 13060295</span></a>]</div></li><li><div class="bk_ref" id="Chloramphenicol.R16">Hodgkinson R. Blood dyscrasias associated with chloramphenicol. An investigation into the cases in the British Isles. Lancet 1954; 266 (6806): 285-7.  [<a href="/pubmed/13131842" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 13131842</span></a>]<div><i>(Mailed survey identified 31 cases of blood dyscrasias arising after administration of chloramphenicol in the UK, 28 aplastic anemia, 3 granulocytopenia, 8 [26%] preceded by jaundice, in all ages, 11 children, 13 male and 18 female, 24 fatal).</i></div></div></li><li><div class="bk_ref" id="Chloramphenicol.R17">Abbott VC, Marra JJ, Gell JW. Acute yellow atrophy of the liver following chloramphenicol (chloromycetin) therapy. J Mich State Med Soc 1955; 54: 474-6.  [<a href="/pubmed/14368249" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 14368249</span></a>]<div><i>(53 year old woman developed jaundice and rapidly fatal acute liver failure after a second prolonged course [~2 months] of oral chloramphenicol [bilirubin and liver tests not given], without evidence of aplastic anemia).</i></div></div></li><li><div class="bk_ref" id="Chloramphenicol.R18">Cable JV, Reid JD. Jaundice and aplastic anaemia following chloramphenicol therapy. N Z Med J 1957; 56: 532-5.  [<a href="/pubmed/13483950" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 13483950</span></a>]<div><i>(14 year old girl developed jaundice shortly after a 30 day course of chloramphenicol for acne [bilirubin 60 mg/dL, ALT not available, Alk P normal], which resolved over the next month, followed by easy bruising and evidence of aplastic anemia which led to death one month later).</i></div></div></li><li><div class="bk_ref" id="Chloramphenicol.R19">Brunton L, Shapiro L. Chloramphenicol and aplastic anemia: report of four cases. Can Med Assoc J 1962; 86: 863-5.  [<a href="/pmc/articles/PMC1849189/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1849189</span></a>] [<a href="/pubmed/13874077" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 13874077</span></a>]<div><i>(Four cases of aplastic anemia developing in 3 men and one woman, ages 40-81 years, presenting with bleeding, having received chloramphenicol within the previous two months, 3 fatal, no mention of jaundice or hepatitis).</i></div></div></li><li><div class="bk_ref" id="Chloramphenicol.R20">Foot EC, Thomson WB. Cholestatic jaundice after chloramphenicol. Br Med J 1963; 1 (5327): 403-4.  [<a href="/pmc/articles/PMC2123872/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2123872</span></a>] [<a href="/pubmed/13958656" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 13958656</span></a>]<div><i>(54 year old man developed jaundice two months after starting intermittent chloramphenicol for urinary tract infections [bilirubin 19 mg/dL, ALT 305 U/L, Alk P 2.3 times ULN], with subsequent pancytopenia and death from sepsis).</i></div></div></li><li><div class="bk_ref" id="Chloramphenicol.R21">Gjone E, Orning OM. Jaundice due to chloramphenicol. Acta Hepatosplenol 1966; 13: 288-92.  [<a href="/pubmed/5994989" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 5994989</span></a>]<div><i>(25 year old woman developed fatigue followed by jaundice on 4 occasions over a four year period [AST 210, 2160, 2120 and 426, Alk P twice normal], each episode preceded by a course of chloramphenicol).</i></div></div></li><li><div class="bk_ref" id="Chloramphenicol.R22">Rubin E, Gottlieb C, Vogel P. Syndrome of hepatitis and aplastic anemia. Am J Med 1968; 45: 88-97.  [<a href="/pubmed/5658873" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 5658873</span></a>]<div><i>(Description of 9 cases of jaundice followed by pancytopenia and aplasia of unknown cause, suspected to be due to a form of viral hepatitis).</i></div></div></li><li><div class="bk_ref" id="Chloramphenicol.R23">Wallerstein RO, Condit PK, Kasper CK, Brown JW, Morrison FR. Statewide study of chloramphenicol therapy and fatal aplastic anemia. JAMA 1969; 208: 2045-50.  [<a href="/pubmed/5818983" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 5818983</span></a>]<div><i>(Review of death certificates and pharmacy records in California over 18 month period identified 60 deaths attributed to aplastic anemia, among whom 8 had recently received chloramphenicol representing a risk for aplastic anemia of ~1 per 36,000 persons exposed to chloramphenicol).</i></div></div></li><li><div class="bk_ref" id="Chloramphenicol.R24">Furuyama M, Matsuda I. Chloramphenicol and jaundice in a baby. Lancet 1967; 2 (7511): 366-7.  [<a href="/pubmed/4143738" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 4143738</span></a>]<div><i>(2 month old child developed jaundice 16 days after starting intramuscular injections of chloramphenicol [bilirubin ~4-5 mg/dL, ALT 40-75 U/L, Alk P not given], resolving rapidly after stopping antibiotic).</i></div></div></li><li><div class="bk_ref" id="Chloramphenicol.R25">Polak BC, Wesseling H, Schut D, Herxheimer A, Meyler L. Blood dyscrasias attributed to chloramphenicol. A review of 576 published and unpublished cases. Acta Med Scand 1972; 192: 409-14.  [<a href="/pubmed/5083381" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 5083381</span></a>]<div><i>(Analysis of 576 cases of blood dyscrasias attributed to chloramphenicol, 70% had pancytopenia, mortality was independent of age or sex; no mention of liver injury or jaundice).</i></div></div></li><li><div class="bk_ref" id="Chloramphenicol.R26">Hodgkinson R. The chloramphenicol--hepatitis--aplastic anaemia syndrome. Med J Aust 1973; 1: 939-40.  [<a href="/pubmed/4715401" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 4715401</span></a>]<div><i>(Five cases of aplastic anemia and hepatitis, presenting with fatigue and jaundice with aplastic anemia arising during recovery, but resulting in death over long term).</i></div></div></li><li><div class="bk_ref" id="Chloramphenicol.R27">Ito M, Fukuiya Y. [Hepatitis-aplastic anemia syndrome (after the administration of chloramphenicol) (author's transl)]. Rinsho Ketsueki 1974 Sep; 15 (9): 985-92.  [<a href="/pubmed/4612200" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 4612200</span></a>]<div><i>(32 year old woman developed jaundice 4 weeks after a 4 week course of chloramphenicol [bilirubin 25.2 mg/dL, ALT 1100 U/L, Alk P 1.2 times ULN], resolving over the next few weeks, but then developing thrombocytopenia followed by fatal aplastic anemia).</i></div></div></li><li><div class="bk_ref" id="Chloramphenicol.R28">Shibata A, Fukuda M. [Chloramphenicol-hepatitis-aplastic anemia syndrome]. Nihon Rinsho 1977; 35 Suppl 1: 970-1. Japanese.  [<a href="/pubmed/613075" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 613075</span></a>]</div></li><li><div class="bk_ref" id="Chloramphenicol.R29">Casale TB, Macher AM, Fauci AS. Complete hematologic and hepatic recovery in a patient with chloramphenicol hepatitis-pancytopenia syndrome. J Pediatr 1982; 101: 1025-7.  [<a href="/pubmed/7143157" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 7143157</span></a>]<div><i>(15 year old boy with chronic granulomatous disease developed fever and liver injury 18 days after starting chloramphenicol for C. violaceum sepsis [bilirubin normal, ALT ~150 U/L, GGT 1160 U/L, platelets 50,000], recovering promptly with stopping).</i></div></div></li><li><div class="bk_ref" id="Chloramphenicol.R30">Yunis AA. Chloramphenicol toxicity: 25 years of research. Am J Med 1989 Sep; 87 (3N): 44N-48N.  [<a href="/pubmed/2486534" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 2486534</span></a>]<div><i>(Review of the metabolism of chloramphenicol and its toxicity to bone marrow elements leads to the hypothesis that a toxic metabolite of the drug is responsible for damage and loss of marrow stem cells).</i></div></div></li><li><div class="bk_ref" id="Chloramphenicol.R31">Doona M, Walsh JB. Use of chloramphenicol as topical eye medication: time to cry halt? BMJ 1995; 310 (6989): 1217-8.  [<a href="/pmc/articles/PMC2549610/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2549610</span></a>] [<a href="/pubmed/7767184" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 7767184</span></a>]<div><i>(Editorial suggesting avoidance of use of ophthalmologic chloramphenicol because of the rare, but fatal complication of aplastic anemia, at least 5 cases of which are described in the literature).</i></div></div></li><li><div class="bk_ref" id="Chloramphenicol.R32">Rayner SA, Buckley RJ. Ocular chloramphenicol and aplastic anaemia. Is there a link? Drug Saf 1996; 14: 273-6.  [<a href="/pubmed/8800624" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8800624</span></a>]<div><i>(Review of the evidence for and against the association of chloramphenicol eye drops and aplastic anemia).</i></div></div></li><li><div class="bk_ref" id="Chloramphenicol.R33">Wiholm BE, Kelly JP, Kaufman D, Issaragrisil S, Levy M, Anderson T, Shapiro S. Relation of aplastic anaemia to use of chloramphenicol eye drops in two international case-control studies. BMJ 1998; 316 (7132): 666.  [<a href="/pmc/articles/PMC28472/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC28472</span></a>] [<a href="/pubmed/9522791" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9522791</span></a>]<div><i>(Analyses of registries from two international case control studies of aplastic anemia found none of 426 cases [but 7 of 3118 controls] had a recent history of use of chloramphenicol eye drops).</i></div></div></li><li><div class="bk_ref" id="Chloramphenicol.R34">Lancaster T, Swart AM, Jick H. Risk of serious haematological toxicity with use of chloramphenicol eye drops in a British general practice database. BMJ 1998; 316: 667.  [<a href="/pmc/articles/PMC28473/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC28473</span></a>] [<a href="/pubmed/9522792" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9522792</span></a>]<div><i>(Among 442,543 patients who received chloramphenicol eye drops over a 7 year period in the UK, 3 patients had a subsequent diagnosis of severe hematologic toxicity within the following 3 months, but in each case an alternative diagnosis was possible and the maximal calculated risk was &#x0003c;1 per 100,000 persons exposed).</i></div></div></li><li><div class="bk_ref" id="Chloramphenicol.R35">Wareham DW, Wilson P. Chloramphenicol in the 21st century. Hosp Med 2002; 63 (3): 157-61.  [<a href="/pubmed/11933819" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11933819</span></a>]<div><i>(Review of the current status of chloramphenicol as an antiinfective agent as well as its spectrum of activity, mechanism of action, pharmacokinetics, adverse effects, interactions and clinical uses).</i></div></div></li><li><div class="bk_ref" id="Chloramphenicol.R36">Doshi B, Sarkar S. Topical administration of chloramphenicol can induce acute hepatitis. BMJ 2009; 338: 1699.  [<a href="/pubmed/19525305" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19525305</span></a>]<div><i>(37 year old man developed fatigue and jaundice, 1 week after a 5 day course of chloramphenicol eye drops [bilirubin 1.9 mg/dL, AST 868 U/L, Alk P 224 U/L], resolving over the next 10 months).</i></div></div></li></ul></div><div id="bk_toc_contnr"></div></div></div>
            <div class="post-content"><div><div class="half_rhythm"><a href="/books/about/copyright/">Copyright Notice</a></div><div class="small"><span class="label">Bookshelf ID: NBK548105</span><span class="label">PMID: <a href="/pubmed/31643435" title="PubMed record of this page" ref="pagearea=meta&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">31643435</a></span></div><div style="margin-top:2em" class="bk_noprnt"><a class="bk_cntns" href="/books/n/livertox/">Drug Records</a><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/livertox/Chlorambucil/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/livertox/Chlordiazepoxide/" title="Next page in this title">Next &gt;</a></div></div></div></div>
            
        </div>

        <!-- Custom content below content -->
        <div class="col4">
            
        </div>
        
        
        <!-- Book content -->
        
        <!-- Custom contetnt below bottom nav -->
        <div class="col5">
            
        </div>
    </div>

    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            <div id="ncbi_share_book"><a href="#" class="ncbi_share" data-ncbi_share_config="popup:false,shorten:true" ref="id=NBK548105&amp;db=books">Share</a></div>

        </div>
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Views</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PDF_download" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/NBK548105/?report=reader">PubReader</a></li><li><a href="/books/NBK548105/?report=printable">Print View</a></li><li><a data-jig="ncbidialog" href="#_ncbi_dlg_citbx_NBK548105" data-jigconfig="width:400,modal:true">Cite this Page</a><div id="_ncbi_dlg_citbx_NBK548105" style="display:none" title="Cite this Page"><div class="bk_tt">LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012-.  Chloramphenicol. [Updated 2017 Jan 24].<span class="bk_cite_avail"></span></div></div></li><li><a href="/books/NBK548105/pdf/Bookshelf_NBK548105.pdf">PDF version of this page</a> (118K)</li><li><a href="#" class="toggle-glossary-link" title="Enable/disable links to the glossary">Disable Glossary Links</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Bulk Download</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="source-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://ftp.ncbi.nlm.nih.gov/pub/litarch/29/31/" ref="pagearea=source-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Bulk download LiverTox data from FTP</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Overviews</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="source-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/n/livertox/intro/">Introduction</a></li><li><a href="/books/n/livertox/Causality/">Causality</a></li><li><a href="/books/n/livertox/ClinicalCourse/">Clinical Course</a></li><li><a href="/books/n/livertox/ClinicalOutcome/">Clinical Outcomes</a></li><li><a href="/books/n/livertox/ImmuneFeatures/">Immune Features</a></li><li><a href="/books/n/livertox/DrugCategory/">Likelihood Scale</a></li><li><a href="/books/n/livertox/Phenotypes_intro/">Phenotypes</a></li><li><a href="/books/n/livertox/Severity/">Severity Grading</a></li><li><a href="/books/n/livertox/CaseReport/">Writing a Case Report</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Support Links</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="source-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/n/livertox/">LiverTox Homepage</a></li><li><a href="/books/n/livertox/aboutus/">About LiverTox</a></li><li><a href="/books/n/livertox/editorsandreviewers/">Editors and Review Committee</a></li><li><a href="/books/n/livertox/alert/">Meetings and News</a></li><li><a href="/books/n/livertox/abbreviation/">Abbreviations Used</a></li><li><a href="/books/n/livertox/glossary/">Glossary</a></li><li><a href="/books/n/livertox/resource/">Information Resources</a></li><li><a href="/books/n/livertox/disclaimer/">User/Medical Advice Disclaimer</a></li><li><a href="/books/n/livertox/Contactus/">Contact Us</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>OTHER REFERENCE LINKS</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/sites/entrez?cmd=search&amp;db=pubmed&amp;pubmedfilters=true&amp;term=Chloramphenicol/AE+AND+Human%5BMH%5D+AND+(jaundice/CI+OR+bile+duct+diseases/CI+OR+liver/DE+OR+liver+diseases/CI+OR+hepatitis,+toxic%5BMH%5D)" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Recent References on Chloramphenicol: from PubMed.gov</a></li><li><a href="https://clinicaltrials.gov/ct2/results?term=Chloramphenicol" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Trials on Chloramphenicol: from ClinicalTrials.gov</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Related information</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="discovery_db_links" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pmc&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pmc_refs&amp;IdsFromResult=4865280" ref="log$=recordlinks">PMC</a><div class="brieflinkpop offscreen_noflow">PubMed Central citations</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pcsubstance&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pcsubstance&amp;IdsFromResult=4865280" ref="log$=recordlinks">PubChem Substance</a><div class="brieflinkpop offscreen_noflow">Related PubChem Substances</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pubmed&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pubmed_refs&amp;IdsFromResult=4865280" ref="log$=recordlinks">PubMed</a><div class="brieflinkpop offscreen_noflow">Links to PubMed</div></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Similar articles in PubMed</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PBooksDiscovery_RA" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/3055188" ref="ordinalpos=1&amp;linkpos=1&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Aplastic anemia associated with parenteral chloramphenicol: review of 10 cases, including the second case of possible increased risk with cimetidine.</a><span class="source">[Rev Infect Dis. 1988]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Aplastic anemia associated with parenteral chloramphenicol: review of 10 cases, including the second case of possible increased risk with cimetidine.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">West BC, DeVault GA Jr, Clement JC, Williams DM. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Rev Infect Dis. 1988 Sep-Oct; 10(5):1048-51. </em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/14064991" ref="ordinalpos=1&amp;linkpos=2&amp;log$=relatedarticles&amp;logdbfrom=pubmed">CHLORAMPHENICOL TOXICITY IN LIVER AND RENAL DISEASE.</a><span class="source">[Arch Intern Med. 1963]</span><div class="brieflinkpop offscreen_noflow">CHLORAMPHENICOL TOXICITY IN LIVER AND RENAL DISEASE.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">SUHRLAND LG, WEISBERGER AS. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Arch Intern Med. 1963 Nov; 112:747-54. </em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/782836" ref="ordinalpos=1&amp;linkpos=3&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Drug-induced anaemias.</a><span class="source">[Drugs. 1976]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Drug-induced anaemias.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Girdwood RH. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Drugs. 1976; 11(5):394-404. </em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/7072798" ref="ordinalpos=1&amp;linkpos=4&amp;log$=relatedarticles&amp;logdbfrom=pubmed">Fatal aplastic anemia following topical administration of ophthalmic chloramphenicol.</a><span class="source">[Am J Ophthalmol. 1982]</span><div class="brieflinkpop offscreen_noflow">Fatal aplastic anemia following topical administration of ophthalmic chloramphenicol.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Fraunfelder FT, Bagby GC Jr, Kelly DJ. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Am J Ophthalmol. 1982 Mar; 93(3):356-60. </em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/14128005" ref="ordinalpos=1&amp;linkpos=5&amp;log$=relatedarticles&amp;logdbfrom=pubmed">[FATAL APLASTIC ANEMIA FOLLOWING CHLORAMPHENICOL MEDICATION].</a><span class="source">[Harefuah. 1964]</span><div class="brieflinkpop offscreen_noflow">[FATAL APLASTIC ANEMIA FOLLOWING CHLORAMPHENICOL MEDICATION].<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">LURIE I, PRUSAK Y. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Harefuah. 1964 Jan 15; 66:53-5. </em></div></div></li></ul><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed_reviews&amp;uid=31643435" ref="ordinalpos=1&amp;log$=relatedreviews_seeall&amp;logdbfrom=pubmed">See reviews...</a><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed&amp;uid=31643435" ref="ordinalpos=1&amp;log$=relatedarticles_seeall&amp;logdbfrom=pubmed">See all...</a></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Recent Activity</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="recent_activity" id="Shutter"></a></div><div class="portlet_content"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" id="HTDisplay" class=""><div class="action"><a href="javascript:historyDisplayState('ClearHT')">Clear</a><a href="javascript:historyDisplayState('HTOff')" class="HTOn">Turn Off</a><a href="javascript:historyDisplayState('HTOn')" class="HTOff">Turn On</a></div><ul id="activity"><li class="ra_rcd ralinkpopper two_line"><a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=1" href="/portal/utils/pageresolver.fcgi?recordid=60467c25739e6e7637c02913">Chloramphenicol - LiverTox</a><div class="ralinkpop offscreen_noflow">Chloramphenicol - LiverTox<div class="brieflinkpopdesc"></div></div><div class="tertiary"></div></li></ul><p class="HTOn">Your browsing activity is empty.</p><p class="HTOff">Activity recording is turned off.</p><p id="turnOn" class="HTOff"><a href="javascript:historyDisplayState('HTOn')">Turn recording back on</a></p><a class="seemore" href="/sites/myncbi/recentactivity">See more...</a></div></div></div>
        
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script type="text/javascript" src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script type="text/javascript">
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2021-03-08T14:33:57-05:00&amp;Snapshot=%2Fprojects%2Fbooks%2FPBooks@9.2&amp;Host=portal105&amp;ncbi_phid=CE8C7B40046641C100000000052D019D&amp;ncbi_session=CE8C7B400467C241_1325SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fbooks%2FNBK548105%2F&amp;Db=pmc&amp;folderID=134&amp;Ncbi_App=bookshelf&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        </div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=books&amp;ncbi_pdid=book-part&amp;ncbi_acc=NBK548105&amp;ncbi_domain=livertox&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/NBK548105/&amp;ncbi_pagename=Chloramphenicol - LiverTox - NCBI Bookshelf&amp;ncbi_bookparttype=chapter&amp;ncbi_app=bookshelf" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE8C7B400467C241_1325SID /projects/books/PBooks@9.2 portal105 v4.1.r621975 Fri, Dec 18 2020 02:56:50 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4192745/js/3879255/4121861/3501987/4008961/3893018/3821238/4062932/4123007/4087685/4076480/3921943/3400083/3426610.js" snapshot="books"></script></body>
</html>